Longeveron Inc. (LGVN) vs ENDRA Life Sciences Inc. (NDRA)
A side-by-side comparison of Longeveron Inc. and ENDRA Life Sciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LGVN
Longeveron Inc.
$2.39HealthcareDelayed quote: Oct 6, 2026, 1:05 PM EDT
NDRA
ENDRA Life Sciences Inc.
$6.30HealthcareDelayed quote: Oct 6, 2026, 12:49 PM EDT
Total return — LGVN vs NDRA
growth of $100 · dividends reinvested · last 6yLGVN -99.7% (-61.2%/yr)NDRA -100.0% (-79.4%/yr)LGVN compounded faster over this window
Log scale — wide-divergence pair
LGVN NDRA
LGVN vs NDRA: by the numbers
- •NDRA is the larger company ($8M vs $7M market cap).
- •Both run net losses; NDRA's is the smaller (0.00% vs -1977.59% net margin).
Metrics side by side
Valuation
| Metric | LGVN | NDRA |
|---|---|---|
| P/S ratio | 6.13 | N/A |
| P/B ratio | 0.70 | 1.27 |
Profitability
| Metric | LGVN | NDRA |
|---|---|---|
| Gross margin | 69.76% | 0.00% |
| Operating margin | -1942.20% | 0.00% |
| Net margin | -1977.59% | 0.00% |
| ROE | -225.67% | -93.77% |
| ROIC | -211.58% | -92.93% |
Growth (annualized)
| Metric | LGVN | NDRA |
|---|---|---|
| Revenue CAGR (5Y) | -21.21% | N/A |
| Total return CAGR (5Y) | -62.60% | -83.91% |
Frequently asked
- How have LGVN and NDRA total returns compared?
- Over the past 5 years, LGVN delivered -62.60% and NDRA delivered -83.91% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.